Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA
Pan, Chen, Zhang et al. investigated the anti-cancer efficacy of CA170, a small molecule agonist of VISTA, on mouse lung tumorigenesis. When combined with a MHCII-directed KRAS peptide vaccine, the authors reported that CA170 suppressed lung tumor development by increasing CD8+ T cell and decreasing...
Saved in:
Main Authors: | Jing Pan, Yao Chen, Qi Zhang, Achia Khatun, Katie Palen, Gang Xin, Li Wang, Chuanjia Yang, Bryon D. Johnson, Charles R. Myers, Shizuko Sei, Robert H. Shoemaker, Ronald A. Lubet, Yian Wang, Weiguo Cui, Ming You |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/25463f045f454089abc25f6e7b64cc74 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PD-1 derived CA-170 is an oral immune checkpoint inhibitor that exhibits preclinical anti-tumor efficacy
by: Pottayil G. Sasikumar, et al.
Published: (2021) -
Explosive eruption, flank collapse and megatsunami at Tenerife ca. 170 ka
by: Raphaël Paris, et al.
Published: (2017) -
Acta Nº170
by: Banco Central de Chile
Published: (2019) -
Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis
by: Na Li, et al.
Published: (2017) -
The immune checkpoint VISTA exhibits high expression levels in human gliomas and associates with a poor prognosis
by: Amina Ghouzlani, et al.
Published: (2021)